1347 related articles for article (PubMed ID: 25887269)
1. Daidzein attenuates lipopolysaccharide-induced acute lung injury via toll-like receptor 4/NF-kappaB pathway.
Feng G; Sun B; Li TZ
Int Immunopharmacol; 2015 Jun; 26(2):392-400. PubMed ID: 25887269
[TBL] [Abstract][Full Text] [Related]
2. Fisetin Alleviates Lipopolysaccharide-Induced Acute Lung Injury via TLR4-Mediated NF-κB Signaling Pathway in Rats.
Feng G; Jiang ZY; Sun B; Fu J; Li TZ
Inflammation; 2016 Feb; 39(1):148-157. PubMed ID: 26272311
[TBL] [Abstract][Full Text] [Related]
3. Ulinastatin post-treatment attenuates lipopolysaccharide-induced acute lung injury in rats and human alveolar epithelial cells.
Luo Y; Che W; Zhao M
Int J Mol Med; 2017 Feb; 39(2):297-306. PubMed ID: 27959396
[TBL] [Abstract][Full Text] [Related]
4. Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-κB signaling pathway and MMP-9 expression.
Zhang X; Sun CY; Zhang YB; Guo HZ; Feng XX; Peng SZ; Yuan J; Zheng RB; Chen WP; Su ZR; Huang XD
J Ethnopharmacol; 2016 Jun; 186():91-102. PubMed ID: 27036629
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronan ameliorates LPS-induced acute lung injury in mice via Toll-like receptor (TLR) 4-dependent signaling pathways.
Xu C; Chen G; Yang W; Xu Y; Xu Y; Huang X; Liu J; Feng Y; Xu Y; Liu B
Int Immunopharmacol; 2015 Oct; 28(2):1050-8. PubMed ID: 26321117
[TBL] [Abstract][Full Text] [Related]
6. Dexmedetomidine attenuates lipopolysaccharide induced acute lung injury in rats by inhibition of caveolin-1 downstream signaling.
Liu J; Huang X; Hu S; He H; Meng Z
Biomed Pharmacother; 2019 Oct; 118():109314. PubMed ID: 31545263
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of cryptotanshinone on lipopolysaccharide-induced acute lung injury in mice.
Tang Y; Chen Y; Chu Z; Yan B; Xu L
Eur J Pharmacol; 2014 Jan; 723():494-500. PubMed ID: 24161915
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of polydatin on lipopolysaccharide-induced acute lung injury through TLR4-MyD88-NF-κB pathway.
Jiang Q; Yi M; Guo Q; Wang C; Wang H; Meng S; Liu C; Fu Y; Ji H; Chen T
Int Immunopharmacol; 2015 Dec; 29(2):370-376. PubMed ID: 26507165
[TBL] [Abstract][Full Text] [Related]
9. Ulinastatin Protects Against LPS-Induced Acute Lung Injury By Attenuating TLR4/NF-κB Pathway Activation and Reducing Inflammatory Mediators.
Cao C; Yin C; Shou S; Wang J; Yu L; Li X; Chai Y
Shock; 2018 Nov; 50(5):595-605. PubMed ID: 29324628
[TBL] [Abstract][Full Text] [Related]
10. Naringin attenuates acute lung injury in LPS-treated mice by inhibiting NF-κB pathway.
Liu Y; Wu H; Nie YC; Chen JL; Su WW; Li PB
Int Immunopharmacol; 2011 Oct; 11(10):1606-12. PubMed ID: 21640201
[TBL] [Abstract][Full Text] [Related]
11. Mogroside IIIE Attenuates LPS-Induced Acute Lung Injury in Mice Partly Through Regulation of the TLR4/MAPK/NF-κB Axis via AMPK Activation.
Tao L; Cao F; Xu G; Xie H; Zhang M; Zhang C
Phytother Res; 2017 Jul; 31(7):1097-1106. PubMed ID: 28512854
[TBL] [Abstract][Full Text] [Related]
12. EphA2 antagonism alleviates LPS-induced acute lung injury via Nrf2/HO-1, TLR4/MyD88 and RhoA/ROCK pathways.
Feng G; Sun B; Liu HX; Liu QH; Zhao L; Wang TL
Int Immunopharmacol; 2019 Jul; 72():176-185. PubMed ID: 30986645
[TBL] [Abstract][Full Text] [Related]
13. The effect of magnolol on the Toll-like receptor 4/nuclear factor κB signaling pathway in lipopolysaccharide-induced acute lung injury in mice.
Yunhe F; Bo L; Xiaosheng F; Fengyang L; Dejie L; Zhicheng L; Depeng L; Yongguo C; Xichen Z; Naisheng Z; Zhengtao Y
Eur J Pharmacol; 2012 Aug; 689(1-3):255-61. PubMed ID: 22683864
[TBL] [Abstract][Full Text] [Related]
14. Glycitin alleviates lipopolysaccharide-induced acute lung injury via inhibiting NF-κB and MAPKs pathway activation in mice.
Chen Y; Guo S; Jiang K; Wang Y; Yang M; Guo M
Int Immunopharmacol; 2019 Oct; 75():105749. PubMed ID: 31306981
[TBL] [Abstract][Full Text] [Related]
15. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways.
Meng L; Li L; Lu S; Li K; Su Z; Wang Y; Fan X; Li X; Zhao G
Mol Immunol; 2018 Feb; 94():7-17. PubMed ID: 29241031
[TBL] [Abstract][Full Text] [Related]
16. Asiaticoside attenuates lipopolysaccharide-induced acute lung injury via down-regulation of NF-κB signaling pathway.
Qiu J; Yu L; Zhang X; Wu Q; Wang D; Wang X; Xia C; Feng H
Int Immunopharmacol; 2015 May; 26(1):181-7. PubMed ID: 25835778
[TBL] [Abstract][Full Text] [Related]
17. Timosaponin B-II inhibits lipopolysaccharide-induced acute lung toxicity via TLR/NF-κB pathway.
Zhang T; Wang J; Wang S; Ma C
Toxicol Mech Methods; 2015; 25(9):665-71. PubMed ID: 26540118
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of taraxasterol on acute lung injury induced by lipopolysaccharide in mice.
San Z; Fu Y; Li W; Zhou E; Li Y; Song X; Wang T; Tian Y; Wei Z; Yao M; Cao Y; Zhang N
Int Immunopharmacol; 2014 Apr; 19(2):342-50. PubMed ID: 24548765
[TBL] [Abstract][Full Text] [Related]
19. Kaempferol regulates MAPKs and NF-κB signaling pathways to attenuate LPS-induced acute lung injury in mice.
Chen X; Yang X; Liu T; Guan M; Feng X; Dong W; Chu X; Liu J; Tian X; Ci X; Li H; Wei J; Deng Y; Deng X; Chi G; Sun Z
Int Immunopharmacol; 2012 Oct; 14(2):209-16. PubMed ID: 22835426
[TBL] [Abstract][Full Text] [Related]
20. Genipin alleviates LPS-induced acute lung injury by inhibiting NF-κB and NLRP3 signaling pathways.
Zhang A; Wang S; Zhang J; Wu H
Int Immunopharmacol; 2016 Sep; 38():115-9. PubMed ID: 27262946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
